Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc
By Akshay Kedari  Date: 2019-12-31

Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc

 

  • Ruling by the US District Court has concluded that Apotex Inc. would be infringing the Alimta vitamin regimen patent by launching its proposed products until the patent expiration of Lilly
     
  • The ruling would bar Apotex from marketing its alternative product until the patent expiration in May 2022

American pharmaceutical company, Eli Lilly and Company, announced that the U.S. District Court (Southern District of Indiana) decided in favor of the company in the Alimta Vitamin Regimen Patent Lawsuit. The court's verdict states that Apotex Inc, a competitor would be liable for infringement of Alimta vitamin regimen patent in the event the company selling generics of the drug prior to the expiration of the patent in May 2022. 

 

Apotex is a Canadian pharmaceutical corporation producing high-quality, affordable generic, as well as innovative pharmaceuticals, for patients across the globe. The ruling would prevent Apotex from marketing its generic form of the lung cancer drug Alimta. Lilly expects the competitor company to appeal the ruling. 

 

For the record, Alimta vitamin regimen is categorized as an antifolate drug, which is designed to bar cells from making DNA through the use of folic acid.

 

Lilly's senior vice president and general counsel, Michael J. Harrington was quoted saying that the company is pleased with the District Court's ruling finding the competitor’s proposition to be a case of infringement. Commenting further on the verdict Harrington stated that Lilly deserves intellectual property protection for its extensive research efforts concentrated on the discovery of the Alimta vitamin regimen. 

 

The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office had also ruled in favor of the company in 2017. Similarly, the U.S. Court of Appeals for the Federal Circuit also upheld the validity of the patent in 2017. 

 

Source credit:

https://investor.lilly.com/news-releases/news-release-details/us-district-court-rules-favor-lilly-alimta-vitamin-regimen-0

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

UV Angel ties up with Smile One Services, launches new dental products
UV Angel ties up with Smile One Services, launches new dental products
By Akshay Kedari

UV Angel, a company renowned in the field of pathogen control technology, has recently announced that it has partnered with Smile One Services, which is dental service organization (DSO)  based in Michigan. Reportedly, the partnership has been i...

LinkedIn Audience Network prefers IAS to offer native ad brand safety
LinkedIn Audience Network prefers IAS to offer native ad brand safety
By Akshay Kedari

Integral Ad Science (IAS), a renowned leader in digital ad verification, has recently announced its agreement with the LinkedIn Audience Network to offer brand safety to native ads on mobile, web, in-app and desktop. The integration tends to utilize ...

SaalexIT acquires Oregon-based Arctic MSP for an undisclosed amount
SaalexIT acquires Oregon-based Arctic MSP for an undisclosed amount
By Akshay Kedari

SaalexIT, a full-service IT company and a market-leading MSSP (Managed Security Service Provider), has reportedly announced its acquisition of Oregon-based Arctic MSP. It is to be noted that the financial terms are yet to be released. The acquisitio...

Virgin Orbit prepares for its first launch mission into the orbit
Virgin Orbit prepares for its first launch mission into the orbit
By Akshay Kedari

Virgin Orbit had recently announced that its LauncherOne air-launched vehicle shall be marking its first flight in the coming days. The company has, however, set modest expectations regarding the probability of success. The company has commented tha...

Cognosante inks acquisition of EIS to expand Federal market offerings
Cognosante inks acquisition of EIS to expand Federal market offerings
By Akshay Kedari

Cognosante, a business process and technology solutions provider, has reportedly announced the acquisition of Vienna-based Enterprise Information Services, LLC. The acquisition of EIS will serve as a growth strategy of the company for expanding its o...